Real-time enrollment status for this lymphangioleiomyomatosis (lam) clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 2:26 PM UTC
| NCT Number | NCT06889168 |
| Recruiting Status | Recruiting |
| Condition | Lymphangioleiomyomatosis (LAM) |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Columbia University |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of October 15, 2026: Clinical trial NCT06889168 is currently recruiting participants. This phase1 study for lymphangioleiomyomatosis (lam) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Columbia University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06889168 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06889168 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.